Page 2 - Ericf Morand News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ericf Morand. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ericf Morand Today - Breaking & Trending Today

Bristol Myers Squibb: Late-Breaking Data at EULAR 2022 Demonstrate Deucravacitinib Significantly Improved Disease Activity in Phase 2 PAISLEY Study in Systemic Lupus Erythematosus

Published: June 1, 2022

Deucravacitinib showed statistically significant efficacy at primary endpoint of Systemic Lupus Erythematosus (SLE) Responder Index-4 (SRI(4)) responses versus placebo at Week 32 Secondary endpoints

Source: finanznachrichten.de

Related Topics:

South AustraliaJonathan SadehBristol Myers SquibbEricf MorandMonash UniversityBristol Myers Squibb CompanyJapan Ministry Of HealthHead Of The School Clinical SciencesFibrosis DevelopmentEuropean Medical AssociationDrug AdministrationEuropean Alliance Of AssociationsExchange CommissionBritish Isles Lupus Assessment GroupSystemic Lupus International Collaborating ClinicsSystemic Lupus ErythematosusMyers SquibbEuropean AllianceClinical SciencesLupus Low Disease Activity StateCutaneous Lupus Erythematosus Disease AreaSeverity IndexBristol MyersIsles Lupus Assessment GroupComposite Lupus Assessment